Evan Lippman
Evp, Business Development at Teva Pharmaceutical Industries Ltd (TEVA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 19SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 18,60025,591 held (−42%) | $36.57 | $680K | +13.5% |
| May 18SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 5,7466,095 held (−49%) | $35.58 | $204K | +16.6% |
| May 18SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 35,91244,191 held (−45%) | $35.58 | $1.3M | +16.6% |
- Sell
Evp, Business Development Evan Lippman sold $680K of TEVA at $36.57 — cuts the stake by 42%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Business Development Evan Lippman sold $204K of TEVA at $35.58 — cuts the stake by 49%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Business Development Evan Lippman sold $1.3M of TEVA at $35.58 — cuts the stake by 45%; pre-scheduled 10b5-1 plan sale.